Fundraising FoxHadean Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsKurma PartnersBpifranceAgoranovPontifax Venture CapitalSunstone CapitalV-Bio Ventures
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Co-investorsBioMedPartnersInkefEQT Life SciencesFund+Sunstone Capital
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Roopom Banerjee(Executive Chairman)in
Co-investorsFSGLU InnovationSciety
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.